Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,767,031,432
+$1,117,571,095 QoQ
Shares Held
4,808,143
-4.9% QoQ
Ownership
0.511%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#28
of 4,621 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Amundi holds $20,539,050,875 across 14 Drug Manufacturers - General names. LLY ranks #1 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
4,808,143 | $5,767,031,432 | |
| 2 | JNJ |
Johnson & Johnson
|
13,117,657 | $3,331,491,343 | |
| 3 | AZN |
Astrazeneca PLC
|
16,422,784 | $3,114,088,296 | |
| 4 | ABBV |
AbbVie Inc.
|
10,039,289 | $2,526,286,678 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,342,274 | $1,585,982,207 | |
| 6 | AMGN |
Amgen Inc
|
3,890,189 | $1,408,715,236 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,772,438 | $1,234,649,812 | |
| 8 | PFE |
Pfizer Inc
|
33,533,616 | $807,489,467 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,767,031,432 | 4,808,143 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $4,649,460,337 | 5,055,025 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,944,039,999 | 4,600,476 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,453,263,226 | 4,525,902 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,776,083,277 | 3,561,227 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,090,837,929 | 4,953,128 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,388,169,812 | 4,388,821 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $4,021,891,171 | 4,539,688 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,614,538,596 | 3,992,289 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,162,976,070 | 4,065,731 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,184,583,040 | 3,747,655 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,364,292,091 | 4,401,713 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,282,695,887 | 4,867,363 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,951,591,630 | 5,682,813 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,669,701,429 | 4,564,021 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,592,413,052 | 4,924,735 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,221,123,767 | 3,766,227 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $1,068,743,423 | 3,732,037 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $949,679,979 | 3,438,129 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $832,583,819 | 3,603,479 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,008,577,879 | 4,394,292 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||